Abstract
This study assessed the significance of hands-on-training (HoT) and questionnaire-based surveys on 3D image-guided brachytherapy (3D-IGBT) and a combination of intracavitary and interstitial brachytherapy, the so-called ‘hybrid’ BT (HBT), in uterine cervical cancer. In October 2023, 29 radiation oncologists, nurses, radiologic technologists and medical physicists from 10 Japanese facilities participated in an HoT on 3D-IGBT and HBT. Questionnaires were distributed to each participant before and after the HoT, and feedback was obtained through online channels. The questionnaire response rate was 83% (24/29), with at least one participant responding from each facility. ‘Insertion of applicators and needles’, ‘human resource shortage’ and ‘pain relief and sedation’ were the primary concerns of radiation oncologists. ‘Applicator reconstruction’, ‘ optimization of dwell positions’, ‘ treatment planning’ and ‘ human resource shortages ’ were the primary concerns of radiological technologists and medical physicists. The HoT content was adjusted according to the results of preliminary surveys. The concerns expressed by the participants were addressed during the lectures and practical training. Significant reductions in anxiety were observed toward all items of the 10-point self-assessment after the HoT, regardless of the profession. The average score on satisfaction with the HoT (on a 10-point scale) was 9.52 (minimum of 8 and maximum of 10). In conclusion, HoT tailored in response to a pre-questionnaire-based survey effectively reduced participants’ anxiety regarding the implementation of 3D-IGBT and HBT.
Keywords: hands-on-training, questionnaire-based survey, 3D image-guided brachytherapy, cervical cancer
INTRODUCTION
Brachytherapy (BT) plays an essential role in the management of patients with uterine cervical cancer. Since the Groupe Europe de Curiethérapie and European Society for Radiotherapy and Oncology proposed the concept of 3D image-guided brachytherapy (3D-IGBT) in 2005, the uptake of this treatment method has spread rapidly worldwide [1, 2]. Recently, favorable results have been reported with the use of magnetic resonance imaging-based- or computed tomography-based 3D-IGBTs [3–6]. Hence, 3D-IGBT is now the standard of care for patients with cervical cancer.
Recently, 3D-IGBT has become increasingly sophisticated, resulting in a combination of intracavitary and interstitial BT, the so-called ‘hybrid’ BT (HBT). HBT has been found to be effective against locally advanced tumors and irregular-shaped tumors [6–8]. HBT was performed in 43.0% of patients according to a recent prospective study [6], indicating that this technique is an essential part of clinical practice.
Effective multidisciplinary education for all healthcare professionals involved in the BT process is critical for successful implementation of 3D-IGBT, particularly HBT [9]. The current options for educating professionals on the use of 3D-IGBT vary in their content [10, 11]. Hands-on-training (HoT) is beneficial for facilities that are introducing HBT for the first time or for improving their techniques because it allows the professionals to learn the procedures directly. The Japanese Society for Radiation Oncology (JASTRO) recommends widespread use of 3D-IGBT and HBT for patients with cervical cancer. The JASTRO established consensus guidelines for HBT for gynecological cancers in 2021 [12] and started HoT for HBT since 2022 [13]. Using this framework, we conducted the second HoT for 3D-IGBT, including HBT, this year, with emphasis on hands-on proficiency.
The concept of HoT and workshops in radiation oncology is not new, and their content and quality are important. To make HoT truly meaningful, it is important to understand in advance what the participants want to learn. It is also important to quantify to what extent participation in the HoT reduces anxiety about implementing HBT. In this regard, we conducted questionnaire-based surveys before and after the HoT. In this study, we report the results of the surveys and briefly discuss the significance of HoT and questionnaire-based surveys.
MATERIALS AND METHODS
The second HoT for 3D-IGBT, including the HBT, was conducted in October 2023. A total of 29 radiation oncologists, nurses, radiologic technologists and medical physicists from 10 Japanese facilities participated in the HoT. Questionnaires were distributed to the participants before and after the HoT, and feedback was obtained through online channels. The pre-questionnaire was distributed 1 week before the HoT. The post-questionnaire was distributed on the day of the HoT, and responses were collected 2 weeks later.
The questionnaire was administered to radiation oncologists, radiologic technologists, medical physicists and nurses and consisted of questions on their concerns about performing HBT. The questionnaire also asked the respondents to rate their level of concern with each HBT procedure on a scale of 1 to 10. In the post-questionnaire survey, the respondents were asked to rate their satisfaction with the HoT on a scale of 1 to 10 and their willingness to proceed with HBT when they encountered patients who may be candidates for it in the future. Details of the pre- and post-course questionnaires are provided in the Supplementary Data 1. Changes in the degree of anxiety before and after the HoT were evaluated using paired-samples t-test. All statistical tests were two-sided, with P < 0.05 designated as the level of statistical significance. Excel (Microsoft, Redmond, WA) for Mac (2021) was used to perform statistical calculations.
RESULTS AND DISCUSSION
The questionnaire response rate was 83% (24/29), with at least one participant responding to each facility. In all, 11 radiation oncologists, 1 nurse, 12 radiologic technologists and medical physicists responded. Regarding the periods in which they had been engaged in gynecological BT, 10 had worked for <1 year, 3, for between 1 and 5 years, and 11, for more than 5 years.
Figure 1 shows the concerns regarding the performance of HBT obtained from the pre-course questionnaire. ‘Insertion of applicators and needles’, ‘human resource shortage’ and ‘pain relief and sedation’ were the primary concerns of radiation oncologists. ‘Applicator reconstruction’, ‘optimization of dwell positions’, ‘treatment planning’ and ‘human resource shortage’ were the primary concerns of radiological technologists and medical physicists. ‘Human resource shortage’ was the primary concern of one nurse who participated in the HoT.
The HoT content was adjusted according to the results of preliminary surveys. The concerns expressed by the participants were addressed in the lectures and practical training. Specifically, participants’ concerns were shared in advance with the instructors. Then, following changes were made:
(1) A workshop was organized in which experts answered basic questions from participants.
(2) Applicator insertion videos were made and presented.
(3) Extended time for medical physicists to explain and demonstrate the tips of the applicator reconstruction.
(4) A lecture and demonstration of a sacral block as a pain relief technique (including hand-made phantoms for the procedure) were provided.
Figure 2 shows the changes in the quantitative responses of participants (radiation oncologists) before and after the course. Significant reductions in anxiety were observed for all items of the 10-point self-assessment of the HoT. In particular, a significant reduction in anxiety was observed with regard to ‘insertion of applicators and needles’ (P < 0.001). Figure 3 shows the changes in the participants’ quantitative responses (radiologic technologists and medical physicists) before and after the course. Similar to the results of radiation oncologists, radiologic technologists and medical physicists showed significant reductions in anxiety toward all items in the 10-point self-assessment of the HoT. All respondents showed a reduction in anxiety about ‘applicator reconstruction’ (P < 0.001). Notably, some participants’ anxiety increased after their participation in the HoT.
The average score on satisfaction with the HoT (on a 10-point scale) was 9.52 (with a minimum of 8 and maximum of 10). The average score on willingness to perform HBT when the participants saw patients who had indications for HBT in the future was 2.10 (1 = definitely yes, 10 = no confidence). With the advancements in 3D-IGBT, HoT and other guidelines have become essential for successful implementation. Recent studies have suggested that theoretical teaching can only partially replace on-site education [14, 15]. Although online learning offers convenience, it has disadvantages such as lack of physical interaction, inability to control the audience’s environment, lack of kinesthetic learning, network interruptions, software incompatibility and hardware malfunctions [16, 17]. Online learning and HoT are complementary. Our study highlights the importance of understanding the participants’ needs in advance to maximize the significance of HoT.
To respond flexibly to the demands of the participants in the HoT, the human resources involved in the provision of the HoT must be of high quality. For our HoT, we were able to gather abundant human resources with the support of the participating institutions and JASTRO. In addition, vendor support is essential to provide practical training using equipment that can be used in actual clinical practice. In one study, a vendor reported that educational initiatives and collaboration between academia and industry are critical for well-developed HoT implementation [18].
Significant reductions in anxiety were observed in all items of the 10-point self-assessment by participating in the HoT, regardless of the profession. However, some participants’ anxiety increased after their participation in the HoT, possibly because of reaffirmation of their own HBT abilities in light of the new skills and knowledge gained through the HoT. A recent BT training survey conducted among radiation oncology residents in Europe suggested the need for a curriculum with easy access to trained instructors [19]. Taken together, systematic and comprehensive follow-up is required for HBT to take root.
A limitation of this study is that it analyzed the results of a survey of a small number of professionals who underwent a single HoT. Furthermore, the true endpoint of the HoT is not participant satisfaction or improved skills and knowledge, but rather the actual provision of HBT to the patients at the participant’s facility. It is critical to provide long-term support to the participants in this HoT to determine whether they can successfully implement HBT.
In conclusion, HoT tailored in response to a pre-questionnaire-based survey effectively reduced participants’ anxiety regarding the implementation of 3D-IGBT and HBT. We hope that through activities such as HoT, more facilities will be able to provide 3D-IGBT and HBT and that high-quality radiation therapy for cervical cancer will become more widely available.
CONFLICT OF INTEREST
Dr Murakami, Dr Okonogi and Dr Shikama report grants from Elekta KK, Chiyoda Technol Co. and Boston Scientific.
FUNDING
This study was supported by a Grant-in-Aid for Scientific Research (22K07779, 23H02869, and 23K07171) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
PRESENTATION AT A CONFERENCE
None.
Supplementary Material
Contributor Information
Noriyuki Okonogi, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Naoya Murakami, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Jun Takatsu, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Kotaro Iijima, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Terufumi Kawamoto, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Masaki Oshima, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Kae Okuma, Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Koji Masui, Department of Radiology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
Kazutoshi Murata, National Institutes for Quantum Science and Technology, QST Hospital, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Hiroyuki Okamoto, Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Ken Yoshida, Department of Radiology, Kansai Medical University Medical Center, 10-15 Fumizono-cho, Moriguchi City, Osaka 570-8507, Japan.
Shin-ei Noda, Department of Radiation Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka City, Saitama 350-1298, Japan.
Haruko Numajiri, Department of Radiation Oncology, Proton Medical Research Center, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan.
Miho Watanabe, Department of Diagnostic Radiology & Radiation Oncology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8677, Japan.
Keisuke Tsuchida, Department of Radiation Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515, Japan.
Yoichi Muramoto, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Tatsuki Karino, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Tatsuya Ohno, Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
Naoto Shikama, Department of Radiation Oncology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
References
- 1. Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–45. 10.1016/j.radonc.2004.12.015. [DOI] [PubMed] [Google Scholar]
- 2. Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77. 10.1016/j.radonc.2005.11.014. [DOI] [PubMed] [Google Scholar]
- 3. Viswanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 2012;11:47–52. 10.1016/j.brachy.2011.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Ohno T, Noda SE, Okonogi N, et al. In-room computed tomography-based brachytherapy for uterine cervical cancer: results of a 5-year retrospective study. J Radiat Res 2017;58:543–51. 10.1093/jrr/rrw121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Murakami N, Kasamatsu T, Wakita A, et al. CT based three-dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer. BMC Cancer 2014;14:447. 10.1186/1471-2407-14-447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Pötter R, Tanderup K, Schmid MP, et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 2021;22:538–47. 10.1016/S1470-2045(20)30753-1. [DOI] [PubMed] [Google Scholar]
- 7. Murakami N, Kobayashi K, Shima S, et al. A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience. BMC Cancer 2019;19:221. 10.1186/s12885-019-5430-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Okonogi N, Murata K, Matsui T, et al. Clinical advantage and outcomes of computed tomography-based transvaginal hybrid brachytherapy performed only by sedation without general or saddle block anesthesia. Cancer Rep 2022;5:e1607. 10.1002/cnr2.1607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Tan LT, Tanderup K, Kirisits C, et al. Education and training for image-guided adaptive brachytherapy for cervix cancer– the (GEC)-ESTRO/EMBRACE perspective. Brachytherapy 2020;19:827–36. 10.1016/j.brachy.2020.06.012. [DOI] [PubMed] [Google Scholar]
- 10. Petereit DG. Increasing global access to brachytherapy: the ABS 300 in 10 initiative and ongoing international efforts. Brachytherapy 2022;21:1–3. 10.1016/j.brachy.2021.09.003. [DOI] [PubMed] [Google Scholar]
- 11. Singer L, Braunstein S, Klopp A, Joyner M. Development and implementation of a simulation-based educational workshop on Gynecological brachytherapy: pilot study at a National Meeting. Pract Radiat Oncol 2019;9:e465–72. 10.1016/j.prro.2019.05.006. [DOI] [PubMed] [Google Scholar]
- 12. Murakami N, Ohno T, Toita T, et al. Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers. J Radiat Res 2022;63:402–11. 10.1093/jrr/rrac011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Murakami N, Masui K, Yoshida K, et al. Hands-on seminar for image-guided adaptive brachytherapy and intracavitary/interstitial brachytherapy for uterine cervical cancer. Jpn J Clin Oncol 2023;53:508–13. 10.1093/jjco/hyad012. [DOI] [PubMed] [Google Scholar]
- 14. Tagliaferri L, Kovács G, Aristei C, et al. Current state of interventional radiotherapy (brachytherapy) education in Italy: results of the INTERACTS survey. J Contemp Brachytherapy 2019;11:48–53. 10.5114/jcb.2019.83137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Kovács G, Tagliaferri L, Valentini V. Is an interventional oncology center an advantage in the service of cancer patients or in the education? The Gemelli Hospital and INTERACTS experience. J Contemp Brachytherapy 2017;9:497–8. 10.5114/jcb.2017.72603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Eansor P, Norris ME, D’Souza LA, et al. Is remote learning as effective as in-person learning for contouring education? A prospective comparison of face-to-face versus online delivery of the anatomy and radiology contouring bootcamp. Int J Radiat Oncol Biol Phys 2022;112:590–9. 10.1016/j.ijrobp.2021.10.011. [DOI] [PubMed] [Google Scholar]
- 17. Hussain STA, Rapole PS, Sethi P, et al. Target volume delineation training in radiation oncology in India: a survey evaluating its status, the need for educational programs and the utility of virtual teaching. Asian Pac J Cancer Prev 2021;22:3875–82. 10.31557/APJCP.2021.22.12.3875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Dizendorf E, Sturdza A, Tagliaferri L, et al. Implementation of online workshops on image-guided adaptive brachytherapy (interventional radiotherapy) in locally advanced cervical cancer: experience of BrachyAcademy. Brachytherapy 2023;22:343–51. 10.1016/j.brachy.2023.01.006. [DOI] [PubMed] [Google Scholar]
- 19. Sturdza AE, Stephanides M, Jurgenliemk-Schulz I, et al. Brachytherapy training survey among radiation oncology residents in Europe. Radiother Oncol 2022;177:172–8. 10.1016/j.radonc.2022.10.030. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.